Michael Weller
University of Zurich · EORTC Study Coordinator · University Hospital Zurich, Neurology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in glioma
69
PubMed author-name match
Trials
Studies that name Michael Weller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07832123 · Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyUniversity of Zurich · not yet recruiting · Glioma : Oligodendroglioma or Astrocytoma · study chair
- Ph3NCT05522660 · Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung CancerETOP IBCSG Partners Foundation · recruiting · Non-Small Cell Lung Cancer, Melanoma · study chair
- N/ANCT05259605 · Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationEuropean Organisation for Research and Treatment of Cancer - EORTC · recruiting · Glioma, Glioneuronal Tumor, Choroid Plexus Tumor · principal investigator
- N/ANCT03770468 · Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in GlioblastomaEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Glioblastoma · principal investigator
- Ph2NCT02850744 · Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma PatientsPIQUR Therapeutics AG · terminated · Glioblastoma Multiforme · principal investigator
- Ph2NCT02669511 · PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System LymphomaPIQUR Therapeutics AG · completed · Primary Central Nervous System Lymphoma · principal investigator
- N/ANCT02495610 · Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPHUniversity of Zurich · completed · Idiopathic Normal Pressure Hydrocephalus · principal investigator
- N/ANCT02307604 · SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial AccessEuropean Organisation for Research and Treatment of Cancer - EORTC · withdrawn · Brain Neoplasms · study chair
- Ph3NCT01502241 · Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the ElderlyHeidelberg University · completed · Glioblastoma, Anaplastic Astrocytoma · study director
- Ph2NCT01443676 · Avastin Plus Radiotherapy in Elderly Patients With GlioblastomaUniversity of Zurich · completed · Glioblastoma · principal investigator
- Ph2NCT00941460 · Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent GlioblastomaProf. Dr. Wolfgang Wick · completed · Glioblastoma · study chair
- Ph3NCT00717210 · Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or TemozolomideNeuro-Oncology Working Group of the German Cancer Society · completed · Anaplastic Astrocytoma, Oligodendroglioma, Oligoastrocytoma · principal investigator
- Ph4NCT00571155 · Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo SurgeryUniversity Hospital Tuebingen · completed · Primary Brain Tumor, Epilepsy · principal investigator
- Ph2NCT00533286 · Do Benzodiazepines Improve the Outcome of Mechanical Physiotherapy for Lumbar Disk ProlapseUniversity Hospital Tuebingen · completed · Pain, Disability, Paresis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioma, ranked by citations from NIH iCite, fetched 2026-11-12 11:36 UTC. The ranking covers the 200 most relevant of 69 PubMed records, and a shared surname and initials can bring in a namesake. All 69 on PubMed
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med · 200518,057 citationsRCR 417.1
- 6,475 citationsRCR 163.8
- 2,180 citationsRCR 79.4
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.JAMA Oncol · 20201,288 citationsRCR 55.9
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.Lancet Oncol · 2017953 citationsRCR 30.9
- 883 citationsRCR 26.0
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.Lancet Oncol · 2012875 citationsRCR 25.1
- Lomustine and Bevacizumab in Progressive Glioblastoma.N Engl J Med · 2017766 citationsRCR 27.5
- NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol · 2009614 citationsRCR 15.6
- Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.Neuro Oncol · 2022489 citationsRCR 33.3